12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

ArsenicTrioxide regulatory update

CTIC submitted an NDA to the FDA for ATO to treat relapsed or refractory acute ...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >